Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 CRO mass spectroscopy services industry 3600 synopsis, 2017 - 2028
2.1.1 Business trends
2.1.2 Service type trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 CRO Mass Spectroscopy Services Market Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Technological advancements
3.3.1.2 Growing outsourcing of R&D activities
3.3.1.3 Growing clinical trials worldwide
3.3.2 Industry pitfalls & challenges
3.3.2.1 Intellectual property right issues
3.3.2.2 Shortage of skilled professionals
3.4 Growth potential analysis
3.4.1 By service type
3.4.2 By end-use
3.5 Porter’s analysis
3.6 Competitive landscape, 2021
3.6.1 Competitive matrix analysis, 2021
3.7 PESTEL analysis
Chapter 4 CRO Mass Spectroscopy Services Market, By Service Type
4.1 Key segment trends
4.2 Proteomics services
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Metabolomics services
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.3.2 Others
4.3.2.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 CRO Mass Spectroscopy Services Market, By End-use
5.1 Key segment trends
5.2 Pharmaceutical & biopharmaceutical companies
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Medical device companies
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 CRO Mass Spectroscopy Services Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2017 - 2028 (USD Million)
6.2.2 Market size, by service type, 2017 - 2028 (USD Million)
6.2.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by service type, 2017 - 2028 (USD Million)
6.2.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by service type, 2017 - 2028 (USD Million)
6.2.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3 Europe
6.3.1 Market size, by country, 2017 - 2028 (USD Million)
6.3.2 Market size, by service type, 2017 - 2028 (USD Million)
6.3.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.4 Germany
6.3.4.1 Market size, by service type, 2017 - 2028 (USD Million)
6.3.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.5 UK
6.3.5.1 Market size, by service type, 2017 - 2028 (USD Million)
6.3.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.6 France
6.3.6.1 Market size, by service type, 2017 - 2028 (USD Million)
6.3.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.7 Italy
6.3.7.1 Market size, by service type, 2017 - 2028 (USD Million)
6.3.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.8 Spain
6.3.8.1 Market size, by service type, 2017 - 2028 (USD Million)
6.3.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country, 2017 - 2028 (USD Million)
6.4.2 Market size, by service type, 2017 - 2028 (USD Million)
6.4.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.4 Japan
6.4.4.1 Market size, by service type, 2017 - 2028 (USD Million)
6.4.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.5 China
6.4.5.1 Market size, by service type, 2017 - 2028 (USD Million)
6.4.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.6 India
6.4.6.1 Market size, by service type, 2017 - 2028 (USD Million)
6.4.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.7 Australia
6.4.7.1 Market size, by service type, 2017 - 2028 (USD Million)
6.4.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5 Latin America
6.5.1 Market size, by country, 2017 - 2028 (USD Million)
6.5.2 Market size, by service type, 2017 - 2028 (USD Million)
6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.4 Brazil
6.5.4.1 Market size, by service type, 2017 - 2028 (USD Million)
6.5.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.5 Mexico
6.5.5.1 Market size, by service type, 2017 - 2028 (USD Million)
6.5.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6 Middle East & Africa
6.6.1 Market size, by country, 2017 - 2028 (USD Million)
6.6.2 Market size, by service type, 2017 - 2028 (USD Million)
6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.4 South Africa
6.6.4.1 Market size, by service type, 2017 - 2028 (USD Million)
6.6.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by service type, 2017 - 2028 (USD Million)
6.6.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Competitive dashboard, 2021
7.2 Charles River Laboratories International, Inc
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Alturas Analytics, Inc.
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 BGI Group
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Creative Proteomics
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Eurofins Scientific
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Evotec SE
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Inotiv, Inc. (formerly Bioanalytical Systems, Inc.)
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Labcorp Drug Development
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 MtoZ-Biolabs Inc.
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 PPD Inc. (part of Thermo Fisher Scientific, Inc.)
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis
7.12 WuXi AppTec
7.12.1 Business overview
7.12.2 Financial data
7.12.3 Product landscape
7.12.4 Strategic outlook
7.12.5 SWOT analysis
7.13 MS Bioworks
7.13.1 Business overview
7.13.2 Financial data
7.13.3 Product landscape
7.13.4 Strategic outlook
7.13.5 SWOT analysis
7.14 Novatia LLC
7.14.1 Business overview
7.14.2 Financial data
7.14.3 Product landscape
7.14.4 Strategic outlook
7.14.5 SWOT analysis
7.15 Alphalyse
7.15.1 Business overview
7.15.2 Financial data
7.15.3 Product landscape
7.15.4 Strategic outlook
7.15.5 SWOT analysis
7.16 Metabolon, Inc.
7.16.1 Business overview
7.16.2 Financial data
7.16.3 Product landscape
7.16.4 Strategic outlook
7.16.5 SWOT analysis
7.17 biocrates life sciences ag
7.17.1 Business overview
7.17.2 Financial data
7.17.3 Product landscape
7.17.4 Strategic outlook
7.17.5 SWOT analysis
7.18 Biognosys
7.18.1 Business overview
7.18.2 Financial data
7.18.3 Product landscape
7.18.4 Strategic outlook
7.18.5 SWOT analysis
7.19 Proteome Sciences
7.19.1 Business overview
7.19.2 Financial data
7.19.3 Product landscape
7.19.4 Strategic outlook
7.19.5 SWOT analysis
7.20 Rapid Novor, Inc
7.20.1 Business overview
7.20.2 Financial data
7.20.3 Product landscape
7.20.4 Strategic outlook
7.20.5 SWOT analysis
7.21 iBET
7.21.1 Business overview
7.21.2 Financial data
7.21.3 Product landscape
7.21.4 Strategic outlook
7.21.5 SWOT analysis
7.22 BioCAT GmbH
7.22.1 Business overview
7.22.2 Financial data
7.22.3 Product landscape
7.22.4 Strategic outlook
7.22.5 SWOT analysis
7.23 Olink Proteomics AB
7.23.1 Business overview
7.23.2 Financial data
7.23.3 Product landscape
7.23.4 Strategic outlook
7.23.5 SWOT analysis
7.24 AxisPharm LLC
7.24.1 Business overview
7.24.2 Financial data
7.24.3 Product landscape
7.24.4 Strategic outlook
7.24.5 SWOT analysis
7.25 Somalogic Inc
7.25.1 Business overview
7.25.2 Financial data
7.25.3 Product landscape
7.25.4 Strategic outlook
7.25.5 SWOT analysis
7.26 Seer Inc
7.26.1 Business overview
7.26.2 Financial data
7.26.3 Product landscape
7.26.4 Strategic outlook
7.26.5 SWOT analysis
